United States · FDA National Drug Code directory

Irbesartan

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
63187-737_0adbcb7c-cbd5-49b6-99a4-cdd876ac278a
Product NDC
63187-737
Form
TABLET
Composition / generic term
Irbesartan
Labeler
Proficient Rx LP
Marketing category
ANDA
Marketing start / end (source format)
20120927
Source listing expiry
20261231

Source-listed ingredients

  • IRBESARTAN — 150 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 10 BLISTER PACK in 1 CARTON (63187-737-10) / 10 TABLET in 1 BLISTER PACK · 63187-737-10
  • 30 TABLET in 1 BOTTLE (63187-737-30) · 63187-737-30
  • 60 TABLET in 1 BOTTLE (63187-737-60) · 63187-737-60
  • 90 TABLET in 1 BOTTLE (63187-737-90) · 63187-737-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →